The UroLift® System for the treatment of Benign Prostatic Hyperplasia (BPH) was the subject of three presentations at the Glasgow, Scotland-held urology event: a study men with acute urinary retention;... Read More
PLEASANTON, Calif. – December 14, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology,... Read More
A new Government scheme announced today selects the UroLift® System as one of seven innovations across all specialisms that are the most transformative for NHS patients ... Read More
WAYNE, PA – June 08, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology,... Read More
PLEASANTON, Calif. – May 16, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology,... Read More
PLEASANTON, Calif. and Boston – May 15, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology,... Read More
PLEASANTON, Calif. and LONDON – March 27, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology,... Read More
PLEASANTON, CA, US March 23, 2017 – NeoTract, Inc., announced today that the largest private health insurer in Ireland, Vhi Group,... Read More
LONDON –The UroLift System treatment for enlarged prostate has been highlighted as a strategically important product for the future of the NHS,... Read More
Results and patient experience may vary. While UroLift® is safe, some side effects may occur. As with any medical procedure,... Read More
US
AU
UK